Proto Labs Debt-to-EBITDA Ratio Growth & History (PRLB)
Proto Labs's debt-to-ebitda ratio was 0.05 for fiscal 2025.
View full Proto Labs company overviewProto Labs annual debt-to-ebitda ratio history
| Fiscal year | Period ended | Debt-to-EBITDA ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 0.05 | −0.01 | −18.05% |
| 2024 | 2024-12-31 | 0.06 | −0.02 | −24.41% |
| 2023 | 2023-12-31 | 0.08 | — | — |
| 2021 | 2021-12-31 | 0.09 | −0.05 | −36.14% |
| 2020 | 2020-12-31 | 0.14 | 0.04 | +34.12% |
| 2019 | 2019-12-31 | 0.11 | 0.11 | — |
| 2018 | 2018-12-31 | 0.00 | −0.06 | — |
| 2017 | 2017-12-31 | 0.06 | 0.06 | — |
| 2016 | 2016-12-31 | 0.00 | 0.00 | — |
| 2015 | 2015-12-31 | 0.00 | −0.00 | — |
| 2014 | 2014-12-31 | 0.00 | −0.00 | −66.28% |
| 2013 | 2013-12-31 | 0.01 | −0.00 | −28.94% |
| 2012 | 2012-12-31 | 0.01 | −0.01 | −55.93% |
| 2011 | 2011-12-31 | 0.02 | — | — |
Proto Labs quarterly debt-to-ebitda ratio
| Fiscal quarter | Period ended | Debt-to-EBITDA ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 0.03 | −0.02 | −41.22% |
| Q1 2026 | 2026-03-31 | 0.04 | −0.02 | −30.48% |
| Q4 2025 | 2025-12-31 | 0.05 | −0.01 | −18.05% |
| Q3 2025 | 2025-09-30 | 0.05 | −0.01 | −23.27% |
| Q2 2025 | 2025-06-30 | 0.05 | −0.01 | −16.36% |
| Q1 2025 | 2025-03-31 | 0.06 | −0.01 | −18.08% |
| Q4 2024 | 2024-12-31 | 0.06 | −0.02 | −24.41% |
| Q3 2024 | 2024-09-30 | 0.06 | — | — |
| Q2 2024 | 2024-06-30 | 0.07 | — | — |
| Q1 2024 | 2024-03-31 | 0.07 | — | — |
| Q4 2023 | 2023-12-31 | 0.08 | — | — |
| Q3 2022 | 2022-09-30 | 0.08 | −0.01 | −15.19% |
| Q2 2022 | 2022-06-30 | 0.08 | −0.06 | −45.75% |
| Q1 2022 | 2022-03-31 | 0.08 | −0.13 | −61.90% |
| Q4 2021 | 2021-12-31 | 0.09 | −0.05 | −36.14% |
| Q3 2021 | 2021-09-30 | 0.09 | −0.04 | −30.08% |
| Q2 2021 | 2021-06-30 | 0.14 | 0.03 | +24.80% |
| Q1 2021 | 2021-03-31 | 0.20 | 0.10 | +97.70% |
| Q4 2020 | 2020-12-31 | 0.14 | 0.04 | +34.12% |
| Q3 2020 | 2020-09-30 | 0.13 | 0.02 | +19.07% |
| Q2 2020 | 2020-06-30 | 0.11 | 0.00 | +2.42% |
| Q1 2020 | 2020-03-31 | 0.10 | −0.00 | −3.26% |
| Q4 2019 | 2019-12-31 | 0.11 | 0.11 | — |
| Q3 2019 | 2019-09-30 | 0.11 | — | — |
| Q2 2019 | 2019-06-30 | 0.11 | — | — |
| Q1 2019 | 2019-03-31 | 0.11 | — | — |
| Q4 2018 | 2018-12-31 | 0.00 | −0.06 | — |
| Q4 2017 | 2017-12-31 | 0.06 | 0.06 | — |
| Q3 2017 | 2017-09-30 | 0.00 | 0.00 | — |
| Q2 2017 | 2017-06-30 | 0.00 | 0.00 | — |
| Q1 2017 | 2017-03-31 | 0.00 | 0.00 | — |
| Q4 2016 | 2016-12-31 | 0.00 | 0.00 | — |
| Q3 2016 | 2016-09-30 | 0.00 | −0.00 | — |
| Q2 2016 | 2016-06-30 | 0.00 | −0.00 | — |
| Q1 2016 | 2016-03-31 | 0.00 | −0.00 | — |
| Q4 2015 | 2015-12-31 | 0.00 | −0.00 | — |
| Q3 2015 | 2015-09-30 | 0.00 | −0.00 | −18.46% |
| Q2 2015 | 2015-06-30 | 0.00 | −0.00 | −20.20% |
| Q1 2015 | 2015-03-31 | 0.00 | −0.00 | −24.91% |
| Q4 2014 | 2014-12-31 | 0.00 | −0.00 | −66.28% |
| Q3 2014 | 2014-09-30 | 0.00 | −0.00 | −83.88% |
| Q2 2014 | 2014-06-30 | 0.00 | −0.00 | −75.56% |
| Q1 2014 | 2014-03-31 | 0.00 | −0.00 | −73.21% |
| Q4 2013 | 2013-12-31 | 0.01 | −0.00 | −28.94% |
| Q3 2013 | 2013-09-30 | 0.00 | −0.01 | −67.07% |
| Q2 2013 | 2013-06-30 | 0.00 | −0.01 | −63.28% |
| Q1 2013 | 2013-03-31 | 0.01 | −0.01 | −61.20% |
| Q4 2012 | 2012-12-31 | 0.01 | −0.01 | −55.93% |
| Q3 2012 | 2012-09-30 | 0.01 | — | — |
| Q2 2012 | 2012-06-30 | 0.01 | — | — |
| Q1 2012 | 2012-03-31 | 0.02 | — | — |
| Q4 2011 | 2011-12-31 | 0.02 | — | — |
Proto Labs debt-to-ebitda ratio trends
Over the last five fiscal years, Proto Labs's debt-to-ebitda ratio decreased from 0.14 to 0.05, a change of −0.09. The latest reported quarter, Q2 2026, shows 0.03.
What the debt-to-EBITDA ratio means
Debt-to-EBITDA compares interest-bearing debt with operating earnings before interest, taxes, depreciation, and amortization. It is commonly used to assess leverage, but it is generally unsuitable for banks and other financial companies.
How debt-to-EBITDA is calculated
TickerStat divides period-end total debt by annual EBITDA. Quarterly observations use trailing-12-month EBITDA. Periods with zero or negative EBITDA are excluded because the leverage multiple would not be meaningful. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Proto Labs source filings ↗